These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30148670)

  • 1. How Do Gay and Bisexual Men Make Up for Missed PrEP Doses, and What Impact Does Missing a Dose Have on Their Subsequent Sexual Behavior?
    Grov C; D'Angelo AB; Flynn AWP; Lopez-Rios J; Pantalone DW; Holloway IW; Whitfield THF; Parsons JT
    AIDS Educ Prev; 2018 Aug; 30(4):275-286. PubMed ID: 30148670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical exigencies, psychosocial realities: negotiating HIV pre-exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada.
    Newman PA; Guta A; Lacombe-Duncan A; Tepjan S
    J Int AIDS Soc; 2018 Nov; 21(11):e25211. PubMed ID: 30474351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gay and Bisexual Men's Strategies to Maintain Daily Adherence to Their HIV Pre-exposure Prophylaxis (PrEP) Medication: Results from a Qualitative Study.
    Grov C; Flynn AWP; D'Angelo AB; Lopez-Rios J; Pantalone DW; Holloway IW; Parsons JT
    Prev Sci; 2019 Jan; 20(1):168-177. PubMed ID: 30637602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-exposure prophylaxis (PrEP) uptake and adherence experiences of gay and bisexual men who engage in chemsex: A qualitative study.
    Maxwell S; Shahmanesh M; Gafos M
    Int J Drug Policy; 2022 May; 103():103630. PubMed ID: 35231668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Pre-Exposure Prophylaxis on Sexual Communication and Sexual Behavior of Urban Gay and Bisexual Men.
    Pantalone DW; Holloway IW; Goldblatt AEA; Gorman KR; Herbitter C; Grov C
    Arch Sex Behav; 2020 Jan; 49(1):147-160. PubMed ID: 31628628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining the Roles that Club Drugs, Marijuana, and Heavy Drinking Play in PrEP Medication Adherence Among Gay and Bisexual Men: Implications for Treatment and Research.
    Grov C; Rendina HJ; John SA; Parsons JT
    AIDS Behav; 2019 May; 23(5):1277-1286. PubMed ID: 30306433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why I Quit Pre-Exposure Prophylaxis (PrEP)? A Mixed-Method Study Exploring Reasons for PrEP Discontinuation and Potential Re-initiation Among Gay and Bisexual Men.
    Whitfield THF; John SA; Rendina HJ; Grov C; Parsons JT
    AIDS Behav; 2018 Nov; 22(11):3566-3575. PubMed ID: 29404756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gay and Bisexual Men's Perceptions of Pre-exposure Prophylaxis (PrEP) in a Context of High Accessibility: An Australian Qualitative Study.
    Philpot S; Prestage G; Holt M; Haire B; Maher L; Hammoud M; Bourne A
    AIDS Behav; 2020 Aug; 24(8):2369-2380. PubMed ID: 31970582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing hypothetical willingness from behavioral intentions to initiate HIV pre-exposure prophylaxis (PrEP): Findings from a large cohort of gay and bisexual men in the U.S.
    Rendina HJ; Whitfield TH; Grov C; Starks TJ; Parsons JT
    Soc Sci Med; 2017 Jan; 172():115-123. PubMed ID: 27866750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of Awareness of and Willingness to Use Pre-exposure Prophylaxis (PrEP) in Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Geosocial-Networking Smartphone Applications in New York City.
    Goedel WC; Halkitis PN; Greene RE; Duncan DT
    AIDS Behav; 2016 Jul; 20(7):1435-42. PubMed ID: 26966013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing determinants of pre-exposure prophylaxis (PrEP) adherence among a sample of rural Midwestern men who have sex with men (MSM).
    Owens C; Hubach RD; Lester JN; Williams D; Voorheis E; Reece M; Dodge B
    AIDS Care; 2020 Dec; 32(12):1581-1588. PubMed ID: 32338061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of Peers on PrEP Perceptions and Use Among Young Black Gay, Bisexual, and Other Men Who Have Sex with Men: A Qualitative Examination.
    Quinn KG; Christenson E; Spector A; Amirkhanian Y; Kelly JA
    Arch Sex Behav; 2020 Aug; 49(6):2129-2143. PubMed ID: 32016815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Club drug users had higher odds of reporting a bacterial STI compared with non-club drug users: results from a cross-sectional analysis of gay and bisexual men on HIV pre-exposure prophylaxis.
    John SA; Parsons JT; Rendina HJ; Grov C
    Sex Transm Infect; 2019 Dec; 95(8):626-628. PubMed ID: 30126949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness to use and have sex with men taking HIV pre-exposure prophylaxis (PrEP): results of online surveys of Australian gay and bisexual men, 2011-2015.
    Holt M; Lea T; Schmidt HM; Kolstee J; Ellard J; Murphy D; Truong HH; de Wit J
    Sex Transm Infect; 2017 Sep; 93(6):438-444. PubMed ID: 28108701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pre-Exposure Prophylaxis-Stigma Paradox: Learning from Canada's First Wave of PrEP Users.
    Grace D; Jollimore J; MacPherson P; Strang MJP; Tan DHS
    AIDS Patient Care STDS; 2018 Jan; 32(1):24-30. PubMed ID: 29185801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will Gay and Bisexual Men Taking Oral Pre-exposure Prophylaxis (PrEP) Switch to Long-Acting Injectable PrEP Should It Become Available?
    John SA; Whitfield THF; Rendina HJ; Parsons JT; Grov C
    AIDS Behav; 2018 Apr; 22(4):1184-1189. PubMed ID: 28913659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study.
    Grulich AE; Jin F; Bavinton BR; Yeung B; Hammoud MA; Amin J; Cabrera G; Clackett S; Ogilvie E; Vaccher S; Vickers T; McNulty A; Smith DJ; Dharan NJ; Selvey C; Power C; Price K; Zablotska I; Baker DA; Bloch M; Brown K; Carmody CJ; Carr A; Chanisheff D; Doong N; Finlayson R; Lewis DA; Lusk J; Martin S; Ooi C; Read P; Ryder N; Smith D; Tuck Meng Soo C; Templeton DJ; Vlahakis E; Guy R;
    Lancet HIV; 2021 Aug; 8(8):e486-e494. PubMed ID: 34217426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorrect Knowledge of Event-Driven PrEP "2-1-1" Dosing Regimen Among PrEP-Experienced Gay and Bisexual Men in Australia.
    Chan C; Vaccher S; Fraser D; Grulich AE; Holt M; Zablotska-Manos I; Prestage GP; Bavinton BR
    J Acquir Immune Defic Syndr; 2022 Jun; 90(2):132-139. PubMed ID: 35135976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NZPrEP Demonstration Project: protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) to determine feasibility, acceptability, adverse and behavioural effects of PrEP provision to gay and bisexual men in publicly funded sexual health clinics in Auckland, New Zealand.
    Azariah S; Saxton P; Franklin R; Forster R; Werder S; Jenkins R
    BMJ Open; 2019 Jun; 9(6):e026363. PubMed ID: 31248921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Daily Adherence to HIV Pre-exposure Prophylaxis in Gay/Bisexual Men in the PRELUDE Demonstration Project.
    Vaccher SJ; Marzinke MA; Templeton DJ; Haire BG; Ryder N; McNulty A; Foster R; Grulich AE; Zablotska IB; ;
    AIDS Behav; 2019 May; 23(5):1287-1296. PubMed ID: 30523489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.